Filer Snapshot

BioAge Labs, Inc. SEC EDGAR Filings

SEC filings, ownership reports, and insider transactions for CIK 0001709941.

Entity Type

Company

Total Filings

135

Latest Filing

21 Apr 2026

Industry

Pharmaceutical Preparations

Save this filer page for the next filing cycle

Keep this page in your research queue, then return to compare new filings with prior context.

Save and revisit

Save this filer page

Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.

Create free account to save and revisit this page

Best next steps

Start with the latest filings table, then open the strongest context page for this filer.

  • Use the filings table to verify the newest submission, form type, and report period.
  • Open the deeper context page only when this filer actually has insider or ownership signal.
Go to latest filings table Open insider trading context
Source: SEC filing ARS

ARS filed on 21 Apr 2026 for CIK 0001709941.

View Source Filing
Symbol
BIOA on Nasdaq
Industry
Pharmaceutical Preparations (Office Of Life Sciences)
Business address
5885 Hollis Street, Suite 370, Emeryville, CA, 94608
State of incorporation
DE
Fiscal year end
31 December

Quick Takeaways

  • BioAge Labs, Inc. is an SEC filer tracked under CIK 0001709941.
  • 135 filings are listed on this profile.
  • Common form coverage includes ARS, DEFA14A, DEF 14A and more.

What Changed

  • Latest filing: ARS filed on 21 Apr 2026.
  • Report period: 31 Dec 2025.

Why This Matters

  • You can quote filing dates and form types directly from the SEC record on this page.
  • Use this profile before deeper ownership or insider analysis to confirm filing history context.

Source Evidence

Source: SEC filing ARS

ARS filed on 21 Apr 2026 for CIK 0001709941.

View Source Filing

Return Loop

Why revisit this filer page

A newly filed ARS can change the filing history, ownership context, or next research path for BioAge Labs, Inc..

Latest source-backed update
ARS filed 21 Apr 2026
Why come back
Revisit after a new SEC filing appears to compare the updated record with prior filings.
  • Latest filing on record: ARS filed 21 Apr 2026.
  • Save this filer if you want a stable place to return after the next filing cycle.
  • Open the latest filing table or ownership context to verify what changed.

Filer freshness comes from SEC EDGAR submission history and related source-backed ownership or portfolio filings when available.

Jump to save and follow actions Open latest filings table

Latest update

What changed recently for BioAge Labs, Inc.

New fact period available

Latest financial period: Q4 2025. Open the source-backed page to inspect the fresh filing or facts context.

Update date

24 Mar 2026

Page type

Company facts

Latest period

Q4 2025

SEC-backed company facts were refreshed from filings filed on 24 Mar 2026.

Open company facts Browse recent public updates

Benchmark Context

Benchmark context for this company

BioAge Labs, Inc. has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest financial period: Q4 2025. That gives you a fresh baseline before you compare this company with peers.

  • Latest company facts filing date: 24 Mar 2026.
  • Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
  • Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

Open company facts Browse metric rankings

Filer Overview

BioAge Labs, Inc. has filed 135 SEC EDGAR filings since 13 Feb 2024. Common forms include ARS, DEFA14A, DEF 14A, 4 and more.

Pharmaceutical Preparations Insider transactions Latest 13F filings

Latest Filings

Recent SEC filings for BioAge Labs, Inc. with direct links to document and filing folders.

Form type Document Filing Description Filing date Reporting date File number(s)
ARS Open ARS document View SEC filing for ARS ARS 21 Apr 2026 31 Dec 2025 001-42279
DEFA14A Open DEFA14A document View SEC filing for DEFA14A DEFA14A 21 Apr 2026 001-42279
DEF 14A Open DEF 14A document | Open XBRL data View SEC filing for DEF 14A DEF 14A 21 Apr 2026 10 Jun 2026 001-42279
4 Open 4 document View SEC filing for 4 03 Apr 2026 01 Apr 2026
144 Open 144 document View SEC filing for 144 01 Apr 2026 001-42279
S-3ASR Open S-3ASR document | Open XBRL data View SEC filing for S-3ASR S-3ASR 24 Mar 2026 333-294568
S-8 Open S-8 document | Open XBRL data View SEC filing for S-8 S-8 24 Mar 2026 333-294564
10-K Open 10-K document | Open XBRL data View SEC filing for 10-K 10-K 24 Mar 2026 31 Dec 2025 001-42279
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 24 Mar 2026 24 Mar 2026 001-42279
4 Open 4 document View SEC filing for 4 03 Mar 2026 02 Mar 2026
4 Open 4 document View SEC filing for 4 03 Mar 2026 01 Mar 2026
144 Open 144 document View SEC filing for 144 02 Mar 2026 001-42279
4 Open 4 document View SEC filing for 4 19 Feb 2026 17 Feb 2026
4 Open 4 document View SEC filing for 4 19 Feb 2026 17 Feb 2026
4 Open 4 document View SEC filing for 4 19 Feb 2026 17 Feb 2026
4 Open 4 document View SEC filing for 4 19 Feb 2026 17 Feb 2026
4 Open 4 document View SEC filing for 4 19 Feb 2026 17 Feb 2026
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 17 Feb 2026 005-94634
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 17 Feb 2026 005-94634
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 13 Feb 2026 005-94634
4 Open 4 document View SEC filing for 4 03 Feb 2026 02 Feb 2026
4 Open 4 document View SEC filing for 4 03 Feb 2026 01 Feb 2026
144 Open 144 document View SEC filing for 144 02 Feb 2026 001-42279
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 22 Jan 2026 21 Jan 2026 001-42279
424B5 Open 424B5 document View SEC filing for 424B5 424B5 22 Jan 2026 333-290688
4 Open 4 document View SEC filing for 4 21 Jan 2026 16 Jan 2026
424B5 Open 424B5 document View SEC filing for 424B5 424B5 20 Jan 2026 333-290688
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 20 Jan 2026 20 Jan 2026 001-42279
4 Open 4 document View SEC filing for 4 15 Jan 2026 13 Jan 2026
4 Open 4 document View SEC filing for 4 15 Jan 2026 13 Jan 2026
144 Open 144 document View SEC filing for 144 13 Jan 2026 001-42279
144 Open 144 document View SEC filing for 144 13 Jan 2026 001-42279
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 12 Jan 2026 12 Jan 2026 001-42279
4 Open 4 document View SEC filing for 4 06 Jan 2026 02 Jan 2026
144 Open 144 document View SEC filing for 144 02 Jan 2026 001-42279
4 Open 4 document View SEC filing for 4 11 Dec 2025 09 Dec 2025
144 Open 144 document View SEC filing for 144 09 Dec 2025 001-42279
4 Open 4 document View SEC filing for 4 05 Dec 2025 04 Dec 2025
144 Open 144 document View SEC filing for 144 04 Dec 2025 001-42279
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 04 Dec 2025 04 Dec 2025 001-42279
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 06 Nov 2025 30 Sep 2025 001-42279
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 06 Nov 2025 06 Nov 2025 001-42279
S-3/A Open S-3/A document View SEC filing for S-3/A S-3/A 05 Nov 2025 333-290690
S-3/A Open S-3/A document View SEC filing for S-3/A S-3/A 05 Nov 2025 333-290688
S-3 Open S-3 document | Open XBRL data View SEC filing for S-3 S-3 02 Oct 2025 333-290690
S-3 Open S-3 document | Open XBRL data View SEC filing for S-3 S-3 02 Oct 2025 333-290688
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 14 Aug 2025 005-94634
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 14 Aug 2025 005-94634
4 Open 4 document View SEC filing for 4 11 Aug 2025 07 Aug 2025
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 06 Aug 2025 30 Jun 2025 001-42279
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 06 Aug 2025 06 Aug 2025 001-42279
4 Open 4 document View SEC filing for 4 09 Jun 2025 05 Jun 2025
4 Open 4 document View SEC filing for 4 09 Jun 2025 05 Jun 2025
4 Open 4 document View SEC filing for 4 09 Jun 2025 05 Jun 2025
4 Open 4 document View SEC filing for 4 09 Jun 2025 05 Jun 2025
4 Open 4 document View SEC filing for 4 09 Jun 2025 05 Jun 2025
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 09 Jun 2025 05 Jun 2025 001-42279
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 04 Jun 2025 04 Jun 2025 001-42279
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 06 May 2025 31 Mar 2025 001-42279
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 06 May 2025 06 May 2025 001-42279
ARS Open ARS document View SEC filing for ARS ARS 17 Apr 2025 31 Dec 2024 001-42279
DEFA14A Open DEFA14A document View SEC filing for DEFA14A DEFA14A 17 Apr 2025 001-42279
DEF 14A Open DEF 14A document View SEC filing for DEF 14A DEF 14A 17 Apr 2025 05 Jun 2025 001-42279
S-8 Open S-8 document View SEC filing for S-8 S-8 20 Mar 2025 333-285980
10-K Open 10-K document | Open XBRL data View SEC filing for 10-K 10-K 20 Mar 2025 31 Dec 2024 001-42279
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 20 Mar 2025 20 Mar 2025 001-42279
4/A Open 4/A document View SEC filing for 4/A 10 Mar 2025 17 Apr 2024
4 Open 4 document View SEC filing for 4 10 Mar 2025 27 Sep 2024
4/A Open 4/A document View SEC filing for 4/A 25 Feb 2025 18 Feb 2025
4 Open 4 document View SEC filing for 4 20 Feb 2025 18 Feb 2025
4 Open 4 document View SEC filing for 4 20 Feb 2025 18 Feb 2025
4 Open 4 document View SEC filing for 4 20 Feb 2025 18 Feb 2025
4 Open 4 document View SEC filing for 4 20 Feb 2025 18 Feb 2025
4 Open 4 document View SEC filing for 4 20 Feb 2025 18 Feb 2025
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 14 Feb 2025 005-94634
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 14 Feb 2025 005-94634
4 Open 4 document View SEC filing for 4 20 Dec 2024 18 Dec 2024
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 14 Nov 2024 005-94634
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 12 Nov 2024 005-94634
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 07 Nov 2024 30 Sep 2024 001-42279
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 07 Nov 2024 07 Nov 2024 001-42279
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 07 Oct 2024 005-94634
SC 13D Open SC 13D document View SEC filing for SC 13D SC 13D 04 Oct 2024 005-94634
4 Open 4 document View SEC filing for 4 03 Oct 2024 01 Oct 2024
4 Open 4 document View SEC filing for 4 01 Oct 2024 27 Sep 2024
SC 13D Open SC 13D document View SEC filing for SC 13D SC 13D 30 Sep 2024 005-94634
4 Open 4 document View SEC filing for 4 27 Sep 2024 27 Sep 2024
4 Open 4 document View SEC filing for 4 27 Sep 2024 25 Sep 2024
4 Open 4 document View SEC filing for 4 27 Sep 2024 17 Apr 2024
4 Open 4 document View SEC filing for 4 27 Sep 2024 25 Sep 2024
4 Open 4 document View SEC filing for 4 27 Sep 2024 17 Apr 2024
4 Open 4 document View SEC filing for 4 27 Sep 2024 26 Mar 2024
4 Open 4 document View SEC filing for 4 27 Sep 2024 19 Aug 2024
4 Open 4 document View SEC filing for 4 27 Sep 2024 17 Apr 2024
8-K Open 8-K document View SEC filing for 8-K 8-K 27 Sep 2024 25 Sep 2024 001-42279
S-8 Open S-8 document View SEC filing for S-8 S-8 26 Sep 2024 333-282352
424B4 Open 424B4 document View SEC filing for 424B4 424B4 26 Sep 2024 333-281901
SEC STAFF LETTER Open SEC STAFF LETTER document View SEC filing for SEC STAFF LETTER 25 Sep 2024
EFFECT Open EFFECT document View SEC filing for EFFECT 25 Sep 2024 333-281901
3 Open 3 document View SEC filing for 3 25 Sep 2024 25 Sep 2024
S-1MEF Open S-1MEF document View SEC filing for S-1MEF S-1MEF 25 Sep 2024 333-282334
3 Open 3 document View SEC filing for 3 25 Sep 2024 25 Sep 2024
3 Open 3 document View SEC filing for 3 25 Sep 2024 25 Sep 2024
3 Open 3 document View SEC filing for 3 25 Sep 2024 25 Sep 2024
3 Open 3 document View SEC filing for 3 25 Sep 2024 25 Sep 2024
3 Open 3 document View SEC filing for 3 25 Sep 2024 25 Sep 2024
3 Open 3 document View SEC filing for 3 25 Sep 2024 25 Sep 2024
3 Open 3 document View SEC filing for 3 25 Sep 2024 25 Sep 2024
3 Open 3 document View SEC filing for 3 25 Sep 2024 25 Sep 2024
3 Open 3 document View SEC filing for 3 25 Sep 2024 25 Sep 2024
3 Open 3 document View SEC filing for 3 25 Sep 2024 25 Sep 2024
3 Open 3 document View SEC filing for 3 25 Sep 2024 25 Sep 2024
CERT Open CERT document View SEC filing for CERT 25 Sep 2024 001-42279
CORRESP Open CORRESP document View SEC filing for CORRESP 25 Sep 2024
S-1/A Open S-1/A document View SEC filing for S-1/A S-1/A 25 Sep 2024 333-281901
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 23 Sep 2024 377-07253
CORRESP Open CORRESP document View SEC filing for CORRESP 23 Sep 2024
CORRESP Open CORRESP document View SEC filing for CORRESP 23 Sep 2024
CORRESP Open CORRESP document View SEC filing for CORRESP 18 Sep 2024
8-A12B Open 8-A12B document View SEC filing for 8-A12B 8-A12B 18 Sep 2024 001-42279
S-1/A Open S-1/A document View SEC filing for S-1/A S-1/A 18 Sep 2024 333-281901
CORRESP Open CORRESP document View SEC filing for CORRESP 12 Sep 2024
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 06 Sep 2024 377-07253
CORRESP Open CORRESP document View SEC filing for CORRESP 03 Sep 2024
S-1 Open S-1 document View SEC filing for S-1 S-1 03 Sep 2024 333-281901
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 09 Aug 2024 377-07253
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 05 Aug 2024
DRS/A Open DRS/A document View SEC filing for DRS/A 05 Aug 2024 377-07253
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 18 Jul 2024 377-07253
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 03 Jul 2024
DRS/A Open DRS/A document View SEC filing for DRS/A 03 Jul 2024 377-07253
SEC STAFF LETTER Open SEC STAFF LETTER document View SEC filing for SEC STAFF LETTER 28 Jun 2024
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 28 Jun 2024 377-07253
DRS Open DRS document View SEC filing for DRS 31 May 2024 377-07253
D Open D document View SEC filing for D 13 Feb 2024 021-505095

About this filer

BioAge Labs, Inc. files with the SEC under CIK 0001709941. This page aggregates EDGAR filings and related ownership activity.

Industry: Pharmaceutical Preparations.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.